Physician profile
Daniel Huq
NPI 1285230474
$5,666.43
in general payments reported to CMS, 2019-2025
21 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $521 · 2023: $2,071 · 2024: $2,450 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,829 · Travel and Lodging: $1,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,828.53 |
| Travel and Lodging | $1,053.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,248.58 | 2021-2025 | Impella |
| Inari Medical, INC. | $1,224.70 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $632.86 | 2022-2025 | Repatha |
| Abbott Laboratories | $584.66 | 2022-2023 | Coroflow, Pressurewire |
| Novo Nordisk INC | $367.63 | 2023-2025 | Wegovy |
| Boston Scientific Corporation | $310.62 | 2021-2024 | Watchman Flx |
| Janssen Pharmaceuticals, INC | $262.80 | 2023 | Xarelto |
| Shockwave Medical, INC | $262.18 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $183.32 | 2022-2024 | Lifevest |
| Edwards Lifesciences Corporation | $164.64 | 2023 | Sapien 3 Ultra Resilia |
| Lexicon Pharmaceuticals, INC. | $124.97 | 2024 | Inpefa |
| Dexcom, INC. | $121.54 | 2025 | Dexcom G6 Transmitter |
| Atricure, INC. | $34.94 | 2023 | |
| Alexion Pharmaceuticals, INC. | $31.35 | 2023 | Soliris |
| Bayer Healthcare Pharmaceuticals INC. | $24.83 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $18.70 | 2025 | Attruby |
| Xeris Pharmaceuticals, INC. | $15.44 | 2023 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.00 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $13.97 | 2024 | Farxiga |
| Merck Sharp & Dohme LLC | $13.57 | 2025 | Pifeltro |
| Cvrx, INC. | $10.13 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Huq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.